Unknown

Dataset Information

0

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.


ABSTRACT: Neuromyelitis optica spectrum disorders (NMOSD) are autoantibody mediated chronic inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead to recurrent attacks of optic neuritis, myelitis and/or brainstem syndromes. In some patients with symptoms of NMOSD, no AQP4-Abs but Abs against myelin-oligodendrocyte-glycoprotein (MOG) are detectable. These clinical syndromes are now frequently referred to as "MOG-encephalomyelitis" (MOG-EM). Here we give an overview on current recommendations concerning diagnosis of NMOSD and MOG-EM. These include antibody and further laboratory testing, MR imaging and optical coherence tomography. We discuss therapeutic options of acute attacks as well as longterm immunosuppressive treatment, including azathioprine, rituximab, and immunoglobulins.

SUBMITTER: Borisow N 

PROVIDER: S-EPMC6206299 | BioStudies | 2018-01-01T00:00:00Z

SECONDARY ACCESSION(S): NCT02003144

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3937859 | BioStudies
2016-01-01 | S-EPMC5831396 | BioStudies
2017-01-01 | S-EPMC5420591 | BioStudies
1000-01-01 | S-EPMC6117869 | BioStudies
2020-01-01 | S-EPMC7326092 | BioStudies
2020-01-01 | S-EPMC7470445 | BioStudies
2020-01-01 | S-EPMC7470615 | BioStudies
2019-01-01 | S-EPMC6884758 | BioStudies
2019-01-01 | S-EPMC6801206 | BioStudies
1000-01-01 | S-EPMC4369279 | BioStudies